Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response

Antimicrob Agents Chemother. 2014;58(1):628. doi: 10.1128/AAC.01535-13.

Authors

Onno W Akkerman¹, Richard van Altena, Mathieu S Bolhuis, Tjip S van der Werf, Jan-Willem Alffenaar

Affiliation

¹ University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents / pharmacokinetics*
Female
Humans
Isoniazid / pharmacokinetics*
Male
Pyrazinamide / pharmacokinetics*
Rifampin / pharmacokinetics*
Tuberculosis, Pulmonary / drug therapy*

Substances

Antitubercular Agents
Pyrazinamide
Isoniazid
Rifampin